发明名称 Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases
摘要 The subject invention pertains to myricanol derivatives, therapeutic compositions, and methods for treatment of neurodegenerative diseases, in particular, neurodegenerative diseases associated with abnormal accumulation of protein tau.
申请公布号 US9598338(B2) 申请公布日期 2017.03.21
申请号 US201314390960 申请日期 2013.04.08
申请人 UNIVERSITY OF SOUTH FLORIDA;THE DEPARTMENT OF VETERANS AFFAIRS 发明人 Dickey Chad;Jinwal Umesh;Calcul Laurent;Baker Bill J.;Lebar Matthew
分类号 A61K31/05;A61P25/28;C07C43/23;C07C69/28;C07C43/21;C07C43/215;C07C47/277;A61K31/11;A61K31/121 主分类号 A61K31/05
代理机构 Saliwanchik, Lloyd & Eisenschenk 代理人 Saliwanchik, Lloyd & Eisenschenk
主权项 1. A method of reducing intracellular tau levels, wherein said method comprises administering, to cells comprising protein tau, an effective amount of a compound of formula A, formula C to formula F, or formula J to formula L: wherein each of R1-R4 of formula A, formula C, formula D, formula F, formula J, formula K, and formula L is, independently, —H or any group that forms an ester or ether bond; wherein each of R1-R8 of formula E is, independently, H or any group that forms an ester or ether bond; whereby intracellular tau level is reduced.
地址 Tampa FL US